Inhibitor of the inflammatory response induced by TNFα and IL-1
AssigneeThe Regents of the University of California
InventorsWarner C. Greene, Xin Lin, Romas Gelezuinas
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsWarner C. Greene, Xin Lin, Romas Gelezuinas
Estimating the term…
The present invention provides the molecular basis for cytokine induction of NF-κB-dependent immune and inflammatory responses, emphasizing a role for both NIK-NIK and NIK-IKK protein—protein interactions. A relatively small region of NIK selectively impairs the NIK-IKK interaction. The present invention provides a novel and highly specific method for modulating NF-κB-dependent immune, inflammatory, and anti-apoptotic responses, based on interruption of the critical protein—protein interaction of NIK and IKK. The present invention provides methods for inhibiting NF-κB-dependent gene expression, using mutant NIK proteins. One embodiment of the present invention provides kinase-deficient NIK mutant proteins that inhibit activation of IKK. Another embodiment of the invention provides N-terminus NIK mutant proteins that bind IKK, thus inhibiting NIK/IKK interaction.
A method for inhibiting a first NIK/IKK protein interaction, the method comprising:
A method for inhibiting activation of an endogenous IKK protein, comprising:
A method for inhibiting phosphorylation of an endogenous IKK protein, the method comprising:
Dependencies are inferred from the claim text.